Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis

References

• de The G. HTLV-1 and chronic progressive encephalomyelopathies: an immunovirological perspective. Roman GC, Osame M, eds. HTLV-1 and the Nervous System. New York: Alan R Liss; 1989:3–8.
   Google Scholar
• Richardson JH, Edwards AJ, Cruickshank JK, et al. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990;64(11):5682–5687. doi:10.1128/jvi.64.11.5682-5687.1990.
   PubMed Web of Science ®Google Scholar
• Watanabe T. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. Blood. 2017;129(9):1071–1081. doi:10.1182/blood-2016-09-692574.
   PubMed Web of Science ®Google Scholar
• Yamagishi M, Suzuki Y, Watanabe T, et al. Clonal selection and evolution of HTLV-1-infected cells driven by genetic and epigenetic alteration. Viruses. 2022;14(3):587. doi:10.3390/v14030587.
   PubMed Web of Science ®Google Scholar
• Tajima K, Hinuma Y. Epidemiology of HTLV-I/II in Japan and the world. In: Takatsuki K, Hinuma Y, Yoshida M, eds. Advances in Adult T-cell Leukemia and HTLV-I Research: Gann Monograph on Cancer Research. Tokyo: Japan Scientific Press; 1992:129–149.
   Google Scholar
• Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415–7419. doi:10.1073/pnas.77.12.7415.
   PubMed Web of Science ®Google Scholar
• Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78(10):6476–6480. doi:10.1073/pnas.78.10.6476.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Seiki M, Yamaguchi K, et al. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T cell leukemia virus in the disease. Proc Natl Acad Sci USA. 1984;81(8):2534–2537. doi:10.1073/pnas.81.8.2534.
   PubMed Web of Science ®Google Scholar
• Boxus M, Twizere JC, Legros S, et al. The HTLV-1 Tax interactome. Retrovirology. 2008;5:76. doi:10.1186/1742-4690-5-76.
   PubMed Web of Science ®Google Scholar
• Mahgoub M, Ysunaga J, Iwami S, et al. Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells. Proc Natl Acad Sci USA. 2018;115(6):E1269–E1278. doi:10.1073/pnas.1715724115.
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2(8452):407–410. doi:10.1016/S0140-6736(85)92734-5.
   PubMed Web of Science ®Google Scholar
• Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy: a new clinical entity. Lancet. 1986;1(8488):1031–1032. doi:10.1016/S0140-6736(86)91298-5.
   PubMed Web of Science ®Google Scholar
• Nakao K, Matsumoto M, Ohba N. Seroprevalence of antibodies to HTLV-I in patients with ocular disorders. Br J Ophthalmol. 1991;75(2):76–78. doi:10.1136/bjo.75.2.76.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Yamaguchi K, Takatsuki K, et al. HTLV-I and uveitis. Lancet. 1992;339(8801):1110. doi:10.1016/0140-6736(92)90699-4.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis. 1992;166(4):943–944. doi:10.1093/infdis/166.4.943.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLVI. Jpn J Cancer Res. 1992;83(3):236–239. doi:10.1111/j.1349-7006.1992.tb00092.x.
   PubMedGoogle Scholar
• Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol. 1992;114(2):123–129. doi:10.1016/S0002-9394(14)73974-1.
   PubMed Web of Science ®Google Scholar
• Lee SY, Matsushita K, Machida J, et al. Human T-cell leukemia virus type 1 infection in hemodialysis patients. Cancer. 1987;60(7):1474–1487. doi:10.1002/1097-0142(19871001)60:7<1474::AID-CNCR2820600712>3.0.CO;2-Y.
   PubMed Web of Science ®Google Scholar
• Nakada K, Yamaguchi K, Furugen S, et al. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer. 1987;40(2):145–148. doi:10.1002/ijc.2910400203.
   PubMed Web of Science ®Google Scholar
• Iwakura Y, Tosu M, Yoshida E, et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science. 1991;253(5023):1026–1028. doi:10.1126/science.1887217.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Matsuoka N, Ida H, et al. Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis. 1992;51(6):769–776. doi:10.1136/ard.51.6.769.
   PubMed Web of Science ®Google Scholar
• Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome. Lancet. 1994;344(8930):1116–1119. doi:10.1016/S0140-6736(94)90630-0.
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Hino S, Amagaski T, et al. Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Jpn J Cancer Res. 1984;75(2):103–105.
   Google Scholar
• Bartholomew C, Saxinger WC, Clark JW, et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA. 1987;257(19):2604–2608. doi:10.1001/jama.1987.03390190082024.
   PubMed Web of Science ®Google Scholar
• Lee H, Swanson P, Shorty VS, et al. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science. 1990;244(4903):471–475. doi:10.1126/science.2655084.
   Web of Science ®Google Scholar
• Kamoi K, Horiguchi N, Kurozumi-Karube H, et al. Horizontal transmission of HTLV-1 causing uveitis. Lancet Infec Dis. 2021;21(4):578. doi:10.1016/S1473-3099(21)00063-3.
   PubMed Web of Science ®Google Scholar
• Ikeda E, Wada K, Yoshimura K, et al. Statistics of uveitis in northern and southern districts in Kyushu. Jpn J Clin Ophthalmol. 1993;47(6):1267–1270.
   Google Scholar
• Yoshimura K, Mochizuki M, Araki S, et al. Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis. Am J Ophthalmol. 1993;116(2):156–163. doi:10.1016/S0002-9394(14)71279-6.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Mochizuki M, Watanabe T, et al. Human T lymphotropic virus type 1 uveitis after Graves’ disease. Br J Ophthalmol. 1994;78(3):163–166. doi:10.1136/bjo.78.3.163.
   PubMed Web of Science ®Google Scholar
• Kamoi K, Okayama A, Izumo S, et al. Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan. Br J Ophthalmol. 2020;104(12):1647–1651. doi:10.1136/bjophthalmol-2019-315675.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467–471. doi:10.1016/S0161-6420(85)34001-0.
   PubMed Web of Science ®Google Scholar
• Nakao K, Ohba N, Matsumoto M. Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33:472–481.
   PubMed Web of Science ®Google Scholar
• Ohba N, Matsumoto M, Sameshima M, et al. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33(1):1–12.
   PubMed Web of Science ®Google Scholar
• Ono A, Ikeda E, Mochizuki M, et al. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves’ disease and disease activities. Jpn J Cancer Res. 1998;89(6):608–614. doi:10.1111/j.1349-7006.1998.tb03262.x.
   PubMedGoogle Scholar
• Yamamoto JH, Segurado AA, Hirata CE, et al. Human T-cell lymphotropic virus type 1 infection and ocular manifestations in San Paulo, Brazil. Arch Ophthalmol. 1999;117(4):513–517. doi:10.1001/archopht.117.4.513.
   PubMedGoogle Scholar
• Takahashi T, Takase H, Urano T, et al. Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up. Ocul Immunol Inflamm. 2000;8(4):235–241. doi:10.1076/ocii.8.4.235.6454.
   PubMed Web of Science ®Google Scholar
• Merle H, Cabre P, Olindo S, et al. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in Martinique (French West Indies). Am J Ophthalmol. 2002;134(2):190–195. doi:10.1016/S0002-9394(02)01521-0.
   PubMed Web of Science ®Google Scholar
• Miyanaga M, Shimizu K, Kawaguchi T, et al. A clinical survey of uveitis in HTLV1 endemic region. Ocul Immunol Inflamm. 2009;17(5):335–341. doi:10.3109/09273940903137667.
   PubMed Web of Science ®Google Scholar
• Terada Y, Kamoi K, Komizo T, et al. Human T cell leukemia virus type 1 and eye diseases. J Ocul Pharmacol Therap. 2017;33(4):216–223.
   PubMed Web of Science ®Google Scholar
• Takeda A, Ishibashi T, Sonoda KH. Epidemiology of uveitis caused by HTLV-1, toxoplasmosis, and tuberculosis; the three leading causes of endemic infectious uveitis in Japan. Ocul Immunol Inflamm. 2017;25(sup1):S19–S23. doi:10.1080/09273948.2016.1253851.
   PubMed Web of Science ®Google Scholar
• Nakao K, Abematsu N, Sakamoto T. Systemic diseases in patients with HTLV-1 associated uveitis. Br J Ophthalmol. 2018;102(3):373–376. doi:10.1136/bjophthalmol-2017-310658.
   PubMed Web of Science ®Google Scholar
• Chew R, Henderson T, Aujla J, et al. Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia. Int Ophthalmol. 2018;38(5):2159–2162. doi:10.1007/s10792-017-0659-3.
   PubMed Web of Science ®Google Scholar
• Saghafi M, Rezaievazdi Z, Nabavi S, et al. HTLV-1 seropervalance in sarcoidosis. A clinical and laboratory study in northeast of Iran. Int J Rheum Dis. 2018;21(6):1309–1313. doi:10.1111/1756-185X.13009.
   PubMed Web of Science ®Google Scholar
• Zong Y, Kamoi K, Kurozumi-Karube H, et al. Mechanism of secondary glaucoma development in HTLV-1 uveitis. Font Microviol. 2022;13:738742.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Mochizuki M, Yamaguchi K. HTLV-1 uveitis (HU). Leukemia. 1997;11:582–584.
   PubMedGoogle Scholar
• Streho M, Delair E, Abad S, et al. Uveitis associated with thyroiditis in HTLV-1 carriers. Rev Med Interne. 2005;26(11):894–896. doi:10.1016/j.revmed.2005.07.007.
   PubMed Web of Science ®Google Scholar
• Kamoi K, Uchimura K, Tojo A, et al. HTLV-1 uveitis and Graves’ disease presenting with sudden onset of blurred vision. Lancet. 2022;399(10319):60. doi:10.1016/S0140-6736(21)02442-9.
   PubMed Web of Science ®Google Scholar
• Ono A, Mochizuki M, Yamaguchi K, et al. Immunological and virological characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Invest Ophthalmol Vis Sci. 1997;38(3):676–689.
   PubMed Web of Science ®Google Scholar
• Sagawa K, Mochizuki M, Masuoka K, et al. Immunopathological mechanisms of human T-cell lymphotropic virus type 1 (HTLV-I) uveitis: detection of HTLV-I infected T cells in the eye and their constitutive cytokine production. J Clin Invest. 1995;95(2):852–858. doi:10.1172/JCI117735.
   PubMed Web of Science ®Google Scholar
• Masuoka K, Sagawa K, Mochizuki M, et al. Polyclonal use of T-cell receptor a for human T cell lymphotropic virus type 1-infected T cells. Invest Ophthalmol Vis Sci. 1995;36(1):254–258.
   PubMed Web of Science ®Google Scholar
• Ono A, Miura T, Araki S, et al. Subtype analysis of HTLV-1 in patients with HTLV-1uveitis. Jpn J Cancer Res. 1994;85(8):767–770. doi:10.1111/j.1349-7006.1994.tb02945.x.
   PubMedGoogle Scholar
• Ono A, Mochizuki M, Yamaguchi K, et al. Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol. 1995;79(3):270–276. doi:10.1136/bjo.79.3.270.
   PubMed Web of Science ®Google Scholar
• Iwanaga M, Watanabe T, Utsunomiya A, et al. Human T-cell leukemia virus type I (THLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211–1219. doi:10.1182/blood-2009-12-257410.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Sugita S, Kamoi K. Immunological homeostasis of the eye. Prog Ret Eye Res. 2013;33:10–27. doi:10.1016/j.preteyeres.2012.10.002.
   PubMed Web of Science ®Google Scholar
• Sugita S, Kawazoe Y, Imai A, et al. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet’s disease. Arthritis Res Ther. 2012;14:R99. doi:10.1186/ar3824.
   PubMed Web of Science ®Google Scholar
• Sugita S, Kawazoe Y, Imai A, et al. Role of IL-22- and TNF-α- producing Th22 cells in uveitis patients with Behcet’s disease. J Immunol. 2013;190:5799–5808. doi:10.4049/jimmunol.1202677.
   PubMed Web of Science ®Google Scholar
• Sugita A, Yamada Y, Kaneko S, et al. Induction of regulatory T cells by infliximab in Behcet’s disease. Invest Ophthalmol Vis Sci. 2011;52(1):476–484. doi:10.1167/iovs.10-5916.
   PubMed Web of Science ®Google Scholar
• Satou Y, Utsunomiya A, Tanabe J, et al. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals. Retrovirology. 2012;9:46. doi:10.1186/1742-4690-9-46.
   PubMed Web of Science ®Google Scholar
• Toulza F, Heaps A, Tanaka Y, et al. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 2008;111(10):5047–5053. doi:10.1182/blood-2007-10-118539.
   PubMed Web of Science ®Google Scholar
• Araya N, Sato T, Yagishita N. HumanT-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease. Viruses. 2011;3(9):1532–1548. doi:10.3390/v3091532.
   PubMed Web of Science ®Google Scholar